Ensysce Biosciences, INC. (ENSCW) SEC Filings — 2025

Filings

• Ensysce Biosciences Files Proxy Materials — DEFA14A · Dec 16, 2025
• Ensysce Seeks Shareholder Nod for $3.6M Capital Raise, Incentive Plan Boost — DEF 14A · Dec 2, 2025
• Ensysce Biosciences, INC. 8-K Filing — 8-K · Nov 17, 2025
• Ensysce's Net Loss Widens 67% Amid Soaring R&D Costs — 10-Q · Nov 14, 2025
• Ensysce Narrows Losses Amid R&D Surge, Grant Influx — 10-Q · Aug 13, 2025
• Ensysce Biosciences Changes Auditors to BDO USA, LLP — 8-K · Jun 5, 2025
• Ensysce Biosciences Files 8-K on Operations — 8-K · May 13, 2025
• Ensysce Biosciences Files 8-K: Material Agreement & Equity Sales — 8-K · Apr 24, 2025
• Ensysce Biosciences Files 8-K — 8-K · Apr 1, 2025
• Ensysce Biosciences Enters Material Definitive Agreement — 8-K · Mar 31, 2025
• Ensysce Biosciences Files 2024 10-K — 10-K · Mar 10, 2025
• Ensysce Biosciences Enters Material Definitive Agreement — 8-K · Feb 4, 2025